What is the recommended lab test for diagnosing celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Lab Test for Celiac Disease

The IgA tissue transglutaminase antibody (tTG-IgA) is the recommended first-line screening test for celiac disease, with total IgA levels measured simultaneously to rule out IgA deficiency. 1, 2, 3

Initial Serologic Testing Approach

  • Order IgA tTG as the primary screening test with sensitivity of 90-96% and specificity >95% in adults, and even higher sensitivity (97.7%) in children at standard thresholds 1, 2, 3

  • Measure total IgA levels concurrently to identify IgA deficiency, which occurs in 1-3% of celiac disease patients and would cause falsely negative IgA-based test results 1, 2, 4, 3

  • Testing must be performed while the patient is consuming gluten (at least 10g daily for 6-8 weeks) because positive serologic results resolve and histologic findings improve with gluten removal 1, 2, 3

Confirmatory Testing Based on Initial Results

  • If tTG-IgA is >10× upper limit of normal, add IgA endomysial antibody (EMA-IgA) as a confirmatory test with excellent specificity of 99.6% 1, 2, 3

  • If IgA deficiency is detected, switch to IgG-based tests including IgG deamidated gliadin peptide (DGP-IgG) or IgG tTG, which have excellent sensitivity and specificity in this population 1, 3

  • If tTG-IgA is negative but clinical suspicion remains high, measure serum IgA level to exclude IgA deficiency, or consider HLA-DQ2/DQ8 testing which has >99% negative predictive value 1, 2, 3

Tests to Avoid

  • Do not use IgA or IgG antigliadin antibodies as the primary screening test, as their diagnostic performance is inferior to tTG-IgA and EMA 1

  • Do not use IgG tTG in patients with normal IgA levels, as IgG-based tests are markedly less sensitive and specific than IgA-based tests in IgA-sufficient individuals 1, 4

  • Routine measurement of serum IgA levels alongside tTG-IgA is not warranted as a first step unless IgA deficiency is strongly suspected based on clinical history 1

Special Population Considerations

  • In children under 2 years of age, combine tTG-IgA testing with IgG and IgA deamidated gliadin peptides for improved sensitivity 3

  • In patients already on a gluten-free diet, they must resume a normal diet with three slices of wheat bread daily for 1-3 months before repeat testing to avoid false-negative results 2

Critical Pitfalls to Avoid

  • Never initiate a gluten-free diet before completing diagnostic testing, as this leads to false-negative serology and inconclusive biopsy results with high strength of evidence 2, 4, 3

  • Do not rely solely on serology without biopsy confirmation in adults, as intestinal biopsy remains the gold standard for diagnosis despite high serologic accuracy 1, 2, 3

  • Recognize that seronegative celiac disease can occur, requiring biopsy for diagnosis when clinical suspicion is high despite negative serology 2

  • Different tTG-IgA assays have varying sensitivity, so interpret results in the context of the specific assay's reference range and performance characteristics 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.